​
​

Silence Therapeutics Ownership | Who Owns Silence Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

Silence Therapeutics Ownership Summary

Silence Therapeutics is owned by 61.70% institutional investors, 16.94% insiders, and 21.36% retail investors. Tcg crossover management is the largest institutional shareholder, holding 7.50% of SLN shares. Polar Capital Biotech S Inc is the top mutual fund, with 2.14% of its assets in Silence Therapeutics shares.

SLN Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockSilence Therapeutics61.70%16.94%21.36%
SectorHealthcare Stocks 47.25%8.01%44.75%
IndustryBiotech Stocks 45.35%7.81%46.83%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Polar Capital Biotech S Inc1.00M2.14%-
BIT Biotech Opportunities S107.30K0.23%6.06K
MEDICAL BioHealth EUR Acc107.00K0.23%-
T. Rowe Price Health Sciences95.65K0.20%95.65K
Galileo - Biotech Innovation Fund S USD58.65K0.13%-
Tema Obesity & Cardiometabolic ETF52.13K0.11%-
Fidelity Nasdaq Composite Index29.42K0.06%-
RIM Global Bioscience EUR17.00K0.04%-
Nicholas Inv - US Small Cap15.77K0.03%15.77K
SPDR® S&P® International Small Cap ETF8.08K0.02%-

SLN Ownership FAQ

Who Owns Silence Therapeutics?

Silence Therapeutics shareholders are primarily institutional investors at 61.70%, followed by 16.94% insiders and 21.36% retail investors. The average institutional ownership in Silence Therapeutics's industry, Biotech Stocks , is 45.35%, which Silence Therapeutics exceeds.

Who owns the most shares of Silence Therapeutics?

Silence Therapeutics’s largest shareholders are Tcg crossover management (3.3M shares, 7.50%), Artal group (2.78M shares, 6.32%), and Lombard odier asset management (usa) (2.41M shares, 5.47%). Together, they hold 19.29% of Silence Therapeutics’s total shares outstanding.

Does Blackrock own Silence Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Silence Therapeutics.

Who is Silence Therapeutics’s biggest shareholder by percentage of total assets invested?

Aquilo capital management is Silence Therapeutics’s biggest shareholder by percentage of total assets invested, with 9.16% of its assets in 500.21K Silence Therapeutics shares, valued at 9.5M$.

Who is the top mutual fund holder of Silence Therapeutics shares?

Polar Capital Biotech S Inc is the top mutual fund holder of Silence Therapeutics shares, with 2.14% of its total shares outstanding invested in 1M Silence Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools